The Limited Times

Now you can see non-English news...

Covid-19: Are monoclonal antibodies likely to promote the emergence of variants?


THE VERIFICATION - Some scientists are concerned about the use of this new treatment. Would another solution, dual therapy, be more effective in the face of variants?



According to several scientists, the current variants (English, South African, Brazilian, etc.) could have developed in immunocompromised people treated with antibodies (recovered from cured patients).

Are doctors playing sorcerer's apprentices with monoclonal antibodies?

To discover

  • Test, isolation: the procedure to follow in the event of a suspicion of Covid-19

To read also: Covid-19: will we not be able to "end this virus" by the end of the year?



It is not a certainty and it was not the current treatments.

However, studies on the monoclonal antibody bamlanivimab have shown the possible appearance of viral resistance, the more frequent the higher the dose administered.

For this reason, the health authorities

This article is for subscribers only.

You have 82% left to discover.

Subscribe: 1 € the first month

Can be canceled at any time


Already subscribed?

Log in

Source: lefigaro

All tech articles on 2021-03-03

You may like

News/Politics 2021-04-08T14:52:31.087Z
Life/Entertain 2021-03-15T09:05:12.380Z
Tech/Game 2021-03-04T00:19:56.448Z

Trends 24h

Tech/Game 2021-04-12T04:05:09.115Z


© Communities 2019 - Privacy